MedPath

Polymyxin B Sulfate and Trimethoprim

Polymyxin B Sulfate andTrimethoprim Ophthalmic Solution, USPSterile

Approved
Approval ID

cf4bd790-291e-4c35-83bb-205fb06753b6

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jan 4, 2011

Manufacturers
FDA

Rebel Distributors Corp

DUNS: 118802834

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

polymyxin B sulfate and trimethoprim

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code21695-335
Application NumberANDA064211
Product Classification
M
Marketing Category
C73584
G
Generic Name
polymyxin B sulfate and trimethoprim
Product Specifications
Route of AdministrationOPHTHALMIC
Effective DateJune 13, 2006
FDA Product Classification

INGREDIENTS (7)

sodium chlorideInactive
Code: 451W47IQ8X
Classification: IACT
polymyxin B sulfateActive
Quantity: 10000 mL in 1 mL
Code: 19371312D4
Classification: ACTIB
BENZALKONIUM CHLORIDEInactive
Quantity: 0.04 mg in 1 mL
Code: F5UM2KM3W7
Classification: IACT
sulfuric acidInactive
Code: O40UQP6WCF
Classification: IACT
waterInactive
Code: 059QF0KO0R
Classification: IACT
sodium hydroxideInactive
Code: 55X04QC32I
Classification: IACT
trimethoprim sulfateActive
Quantity: 1 mg in 1 mL
Code: E377MF8EQ8
Classification: ACTIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Polymyxin B Sulfate and Trimethoprim - FDA Drug Approval Details